Tanaka Kuniya, Shimada Hiroshi, Matsuo Kenichi, Takeda Kazuhisa, Nagano Yasuhiko, Togo Shinji
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
World J Surg. 2008 Aug;32(8):1738-47. doi: 10.1007/s00268-008-9613-x.
Few details of the clinical features of hepatocellular carcinoma (HCC) developing extrahepatic recurrence after a curative resection have been published. The purpose of this study was to clarify the clinicopathologic findings of patients with HCC who experienced extrahepatic metastases.
Clinicopathologic data were available for 119 patients who underwent an R0 resection for HCC. Twenty-three patients who developed extrahepatic metastases during the follow-up period were compared with the patients who remained free from recurrence for at least 5 years after resection (n = 21) or with only intrahepatic recurrences (n = 75).
Patients with extrahepatic recurrences were more likely to have their tumor macro- or microscopically invading the tumor capsule (P < 0.001) and hepatic vein (P = 0.003), a high AFP concentration (P = 0.014), and advanced TNM stage (P = 0.006) than the other patients. As for treatment-related variables, inflow vessel occlusion during hepatectomy was less frequently associated with extrahepatic recurrences than if it were not performed (P < 0.001). By multivariate analysis, absence of tumor invasion to the capsule (relative risk [RR] = 0.080; P = 0.023) or to the hepatic vein (RR = 0.108; P = 0.014) and a hepatectomy in which inflow vessel occlusions were performed (RR = 0.161; P = 0.004) were selected as independent factors for reducing extrahepatic recurrences after a hepatectomy.
In HCC patients, the control of intrahepatic recurrences and extrahepatic recurrences after a hepatectomy is important to improve the prognosis. Inflow occlusion during the hepatectomy may reduce HCC metastases to extrahepatic sites.
关于肝细胞癌(HCC)根治性切除术后发生肝外复发的临床特征的详细报道较少。本研究旨在阐明发生肝外转移的HCC患者的临床病理特征。
119例行HCC根治性切除的患者的临床病理资料可供分析。将随访期间发生肝外转移的23例患者与术后至少5年无复发(n = 21)或仅发生肝内复发(n = 75)的患者进行比较。
与其他患者相比,发生肝外复发的患者肿瘤在宏观或微观上更易侵犯肿瘤包膜(P < 0.001)和肝静脉(P = 0.003),甲胎蛋白浓度较高(P = 0.014),TNM分期较晚(P = 0.006)。至于与治疗相关的变量,肝切除术中进行入肝血管阻断与肝外复发的相关性低于未进行该操作时(P < 0.001)。多因素分析显示,肿瘤未侵犯包膜(相对危险度[RR] = 0.080;P = 0.023)或未侵犯肝静脉(RR = 0.108;P = 0.014)以及进行了入肝血管阻断的肝切除术(RR = 0.161;P = 0.004)被选为降低肝切除术后肝外复发的独立因素。
在HCC患者中,控制肝切除术后的肝内复发和肝外复发对改善预后很重要。肝切除术中的入肝血管阻断可能会减少HCC转移至肝外部位。